CITIGROUP INC - VIR BIOTECHNOLOGY INC ownership

VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 229 filers reported holding VIR BIOTECHNOLOGY INC in Q1 2023. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of VIR BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$2,412,335
-37.2%
257,453
+64.5%
0.00%
-33.3%
Q2 2023$3,838,406
-44.9%
156,478
-47.7%
0.00%
-40.0%
Q1 2023$6,959,987
+8.9%
299,097
+18.5%
0.01%
-16.7%
Q4 2022$6,389,788
+4.0%
252,461
-20.8%
0.01%
+50.0%
Q3 2022$6,146,000
+8.9%
318,780
+43.8%
0.00%0.0%
Q2 2022$5,646,000
+370.1%
221,650
+374.9%
0.00%
+300.0%
Q1 2022$1,201,000
-74.7%
46,670
-58.8%
0.00%
-66.7%
Q4 2021$4,742,000
-1.7%
113,262
+2.2%
0.00%0.0%
Q3 2021$4,823,000
-1.4%
110,814
+7.1%
0.00%0.0%
Q2 2021$4,893,000
+0.3%
103,489
+8.7%
0.00%0.0%
Q1 2021$4,880,000
+754.6%
95,191
+346.4%
0.00%
Q4 2020$571,000
+173.2%
21,322
+249.1%
0.00%
Q3 2020$209,000
-53.2%
6,107
-44.0%
0.00%
Q2 2020$447,000
+391.2%
10,907
+312.4%
0.00%
Q1 2020$91,000
+405.6%
2,645
+83.0%
0.00%
Q4 2019$18,0001,4450.00%
Other shareholders
VIR BIOTECHNOLOGY INC shareholders Q1 2023
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 1,559,142$30,100,00023.79%
SB INVESTMENT ADVISERS (UK) LTD 22,086,280$425,823,0003.26%
Zebra Capital Management LLC 40,104$773,0002.94%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 130,409$2,514,0000.94%
CLARK ESTATES INC/NY 180,000$3,470,0000.77%
Temasek Holdings (Private) Ltd 6,036,821$116,389,9090.70%
SECTOR GAMMA AS 89,808$1,731,0000.45%
Capital Impact Advisors, LLC 13,196$360,0000.36%
SummerHaven Investment Management, LLC 24,927$481,0000.33%
DUALITY ADVISERS, LP 92,712$1,787,0000.20%
View complete list of VIR BIOTECHNOLOGY INC shareholders